John L. Brottem
General Counsel · 6 filings · Latest: Sep 14, 2026
Alamar Biosciences, Inc.
Outset Medical, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
OM | John L. Brottem | General Counsel | Aug 17, 2026 | Sale | $4.39 | 2,632 | $11.6K | 87,475 | |
OM | Brottem John L. | — | Aug 17, 2026 | Proposed Sale | $4.51 | 2,562 | $11.5K | — | |
OM | John L. Brottem | General Counsel | May 15, 2026 | Sale | $3.70 | 2,638 | $9.8K | 30,277 | |
OM | Brottem John L. | — | May 15, 2026 | Proposed Sale | $3.70 | 2,638 | $9.8K | — | |
OM | John L. Brottem | General Counsel | Feb 17, 2026 | Sale | $3.35 | 2,842 | $9.5K | 32,935 | |
OM | Brottem John L. | — | Feb 17, 2026 | Proposed Sale | $3.35 | 2,842 | $9.5K | — | |
OM | John L. Brottem | General Counsel | Jan 21, 2026 | Sale | $5.01 | 1,180 | $5.9K | 35,777 | |
OM | John L. Brottem | General Counsel | Jan 20, 2026 | Sale | $5.12 | 9,314 | $47.7K | 36,957 | |
OM | Brottem John L. | — | Jan 21, 2026 | Proposed Sale | $5.01 | 1,180 | $5.9K | — | |
OM | Brottem John L. | — | Jan 20, 2026 | Proposed Sale | $5.12 | 9,314 | $47.7K | — | |
OM | Brottem John L. | — | Jan 7, 2026 | Proposed Sale | $4.27 | 224 | $956 | — | |
OM | Brottem John L. | — | Nov 17, 2025 | Proposed Sale | $4.60 | 388 | $1.8K | — | |
OM | Brottem John L. | — | Aug 15, 2025 | Proposed Sale | $12.88 | 383 | $4.9K | — | |
OM | Brottem John L. | — | May 15, 2025 | Proposed Sale | $17.82 | 396 | $7.1K | — | |
OM | Brottem John L. | — | Feb 18, 2025 | Proposed Sale | $0.90 | 6,145 | $5.5K | — | |
OM | Brottem John L. | — | Jan 21, 2025 | Proposed Sale | $0.80 | 32,930 | $26.3K | — | |
OM | Brottem John L. | — | Jan 13, 2025 | Proposed Sale | $0.81 | 20,492 | $16.6K | — | |
OM | Brottem John L. | — | Jan 7, 2025 | Proposed Sale | $1.29 | 1,572 | $2.0K | — | |
OM | Brottem John L. | — | Nov 15, 2024 | Proposed Sale | $0.80 | 3,203 | $2.6K | — |